((lp0
VisWord
p1
aVcase
p2
aVstops
p3
aVstem
p4
acnltk.probability
FreqDist
p5
((dp6
S'primary tool'
p7
I1
sS'candidate molecul'
p8
I1
sS'all'
p9
I1
sS'represent'
p10
I1
sS'datum'
p11
I2
sS'reclust'
p12
I1
sS'cutoff'
p13
I2
sS'cancer studi'
p14
I2
sS'tolerance induct'
p15
I1
sS'survival predictions for individual pati'
p16
I1
sS'oci'
p17
I1
sS'morpholog'
p18
I1
sS'nois'
p19
I1
sS'of neural network'
p20
I1
sS'activ'
p21
I1
sS'program'
p22
I1
sS'sens'
p23
I1
sS'cell-like tumor'
p24
I2
sS'analys'
p25
I1
sS'gene panel network'
p26
I1
sS'individual pati'
p27
I2
sS'relative impact'
p28
I1
sS'predict'
p29
I2
sS'risk'
p30
I6
sS'viewpoint'
p31
I1
sS'target antigen'
p32
I2
sS'non-survivor'
p33
I4
sS'express'
p34
I5
sS'expression panel'
p35
I1
sS'preparation for'
p36
I1
sS'efficacious approaches for limiting tumor growth'
p37
I1
sS'candid'
p38
I1
sS'large b-cell lymphoma'
p39
I1
sS'middle-layer neuron'
p40
I5
sS'biopsi'
p41
I1
sS'induct'
p42
I1
sS'oci ly1'
p43
I1
sS'experi'
p44
I1
sS'organ'
p45
I1
sS'informative gen'
p46
I1
sS'list'
p47
I1
sS'iter'
p48
I1
sS'correl'
p49
I1
sS'negative donor'
p50
I1
sS'survival prob'
p51
I1
sS'classification accuraci'
p52
I2
sS'round'
p53
I1
sS'middle layer neuron'
p54
I1
sS'respond'
p55
I1
sS'self-organizing-map'
p56
I1
sS'neuralwork'
p57
I1
sS'training sess'
p58
I2
sS'alizadeh studi'
p59
I1
sS'antigen'
p60
I2
sS'investig'
p61
I1
sS'probability plot'
p62
I1
sS'reserv'
p63
I1
sS'disadvantag'
p64
I1
sS'acute lymphoblastic leukemia'
p65
I1
sS'gene express'
p66
I5
sS'index'
p67
I1
sS'error'
p68
I6
sS'optimum outcome classif'
p69
I1
sS'subselect'
p70
I1
sS'gene clust'
p71
I2
sS'individual scor'
p72
I1
sS'cell'
p73
I1
sS'radiation therapi'
p74
I1
sS'survival probability plot'
p75
I1
sS'network softwar'
p76
I1
sS'vector machin'
p77
I2
sS'impact'
p78
I1
sS'non-linear'
p79
I1
sS'propagation network'
p80
I1
sS'coeffici'
p81
I2
sS'diagnostic accuraci'
p82
I4
sS'prognostic index'
p83
I1
sS'sigmoidal transf'
p84
I1
sS'outcome classif'
p85
I1
sS'k-nearest neighbor'
p86
I1
sS'diagnosing lymphoma'
p87
I1
sS'normal training interv'
p88
I1
sS'cox'
p89
I1
sS'som class'
p90
I1
sS'biological analys'
p91
I1
sS'precis'
p92
I1
sS'svm model'
p93
I1
sS'cancer pati'
p94
I1
sS'three-lay'
p95
I1
sS'studi'
p96
I6
sS'gene'
p97
I40
sS'follow-up donor'
p98
I1
sS'chanc'
p99
I1
sS'new network'
p100
I1
sS'final subset'
p101
I1
sS'cancer'
p102
I2
sS'perou'
p103
I1
sS'error cutoff'
p104
I2
sS'subcategori'
p105
I1
sS'kinase receptor gen'
p106
I1
sS'subselection choic'
p107
I1
sS'poll'
p108
I1
sS'signatur'
p109
I2
sS'plot'
p110
I1
sS'score'
p111
I4
sS'dlbcl'
p112
I6
sS'distinct'
p113
I1
sS'semi-quantitative assess'
p114
I1
sS'microarray data chip'
p115
I1
sS'kaplan mei'
p116
I2
sS'gene profil'
p117
I1
sS'panel network'
p118
I2
sS'criteria'
p119
I3
sS'approaches for limiting tumor growth'
p120
I1
sS'basi'
p121
I1
sS'donor profil'
p122
I2
sS'strategi'
p123
I1
sS'naive intuit'
p124
I1
sS'neuron'
p125
I20
sS'disadvantage of'
p126
I1
sS'numerous recent canc'
p127
I1
sS'inlier'
p128
I1
sS'train'
p129
I14
sS'survival predictions for'
p130
I1
sS'neural network strategi'
p131
I1
sS'relative dependence of th'
p132
I1
sS'cluster'
p133
I1
sS'quartil'
p134
I1
sS'prepar'
p135
I1
sS'work'
p136
I2
sS'mh'
p137
I1
sS'rejection antigen'
p138
I1
sS'backpropagation network'
p139
I1
sS'negative scor'
p140
I1
sS'outcom'
p141
I3
sS'non-tumor'
p142
I1
sS'learn'
p143
I1
sS'immunohistochem'
p144
I1
sS'robin'
p145
I1
sS'overtrain'
p146
I2
sS'prognosis accuraci'
p147
I2
sS'vectors for a neural network'
p148
I2
sS'tumor-expressed gen'
p149
I1
sS'chip'
p150
I2
sS'net profil'
p151
I1
sS'retest'
p152
I1
sS'enhanced identification of'
p153
I1
sS'training iter'
p154
I1
sS'neural network'
p155
I17
sS'contribut'
p156
I1
sS'differenti'
p157
I10
sS'survival predict'
p158
I2
sS'round robin'
p159
I2
sS'for differenti'
p160
I1
sS'situ'
p161
I1
sS'microarray'
p162
I2
sS'clinical outcom'
p163
I1
sS'prognosis classification accuraci'
p164
I1
sS'enhanced identification of cell-typ'
p165
I1
sS'tumor-encoded gen'
p166
I1
sS'tumor growth'
p167
I2
sS'artificial network'
p168
I1
sS'donor pool'
p169
I1
sS'leukemia'
p170
I2
sS'prognostic outcom'
p171
I1
sS'survival categori'
p172
I1
sS'round-robin train'
p173
I1
sS'dhanasekaran'
p174
I1
sS'redund'
p175
I2
sS'fl'
p176
I1
sS'unimpair'
p177
I1
sS'metastatic tumor'
p178
I1
sS'germinal center b cell-like tumor'
p179
I1
sS'attempt'
p180
I1
sS'identification of cell-typ'
p181
I1
sS'relative dependence of'
p182
I1
sS'potential target'
p183
I1
sS'model'
p184
I2
sS'acute myeloid leukemia'
p185
I1
sS'follow-up studi'
p186
I2
sS'qualitative network'
p187
I2
sS'all distinct'
p188
I1
sS'therapi'
p189
I1
sS'precise classif'
p190
I1
sS'influential gen'
p191
I1
sS'momentum coeffici'
p192
I1
sS'for a neural network'
p193
I1
sS'tyrosine kinase receptor gen'
p194
I1
sS'predictions for individual pati'
p195
I1
sS'efficacious approach'
p196
I1
sS'vectors for'
p197
I1
sS'identif'
p198
I2
sS'statistical correl'
p199
I1
sS'absolute best poss'
p200
I1
sS'receptor gen'
p201
I1
sS'overview'
p202
I2
sS'signature gen'
p203
I2
sS'gel'
p204
I1
sS'enhanced identif'
p205
I1
sS'momentum'
p206
I1
sS'non-surviv'
p207
I1
sS'prognostic network'
p208
I1
sS'aml'
p209
I3
sS'gene list'
p210
I1
sS'b-cell lymphoma'
p211
I1
sS'linear neural network'
p212
I1
sS'bit'
p213
I2
sS'lymphoma'
p214
I4
sS'backpropagation neural network'
p215
I1
sS'choic'
p216
I1
sS'efficacious approaches for'
p217
I1
sS'radiat'
p218
I1
sS'non-respons'
p219
I1
sS'gene stag'
p220
I1
sS'subset'
p221
I12
sS'fatal class'
p222
I1
sS'non-respond'
p223
I2
sS'majority vot'
p224
I1
sS'lymphoblastic leukemia'
p225
I1
sS'interv'
p226
I1
sS'potential target antigen'
p227
I1
sS't cell'
p228
I1
sS'marker'
p229
I1
sS'growth'
p230
I1
sS'sampl'
p231
I1
sS'microarray experi'
p232
I1
sS'sight'
p233
I1
sS'year'
p234
I1
sS'malignant phenotyp'
p235
I1
sS'molecul'
p236
I1
sS'binary represent'
p237
I1
sS'network'
p238
I29
sS'cell-typ'
p239
I1
sS'best poss'
p240
I1
sS'categori'
p241
I1
sS'vector'
p242
I8
sS'relative depend'
p243
I1
sS'rm'
p244
I1
sS'gene panel'
p245
I3
sS'cox hazard'
p246
I1
sS'fl patient'
p247
I1
sS'machin'
p248
I1
sS'diseas'
p249
I2
sS'patient'
p250
I12
sS'prognost'
p251
I1
sS'agreement'
p252
I1
sS'target organ'
p253
I1
sS'disadvantage of neural network'
p254
I1
sS'hazard'
p255
I1
sS'tumor rejection antigen'
p256
I1
sS'panel'
p257
I4
sS'session'
p258
I2
sS'prognosi'
p259
I1
sS'tumor'
p260
I10
sS'informative gene mark'
p261
I1
sS'neighbor'
p262
I1
sS'metastatic diseas'
p263
I1
sS'predictor'
p264
I1
sS'softwar'
p265
I2
sS'major'
p266
I2
sS'error-free predict'
p267
I1
sS'non-specific similar'
p268
I1
sS'pairwise similar'
p269
I1
sS'som'
p270
I2
sS'surviv'
p271
I7
sS'assess'
p272
I2
sS'of cell-typ'
p273
I1
sS'survival outcom'
p274
I1
sS'optimum outcom'
p275
I1
sS'antibody-mediated immunotherapi'
p276
I1
sS'vote'
p277
I1
sS'correlation coeffici'
p278
I1
sS'informative subset'
p279
I1
sS'stage'
p280
I1
sS'rms error'
p281
I1
sS'blue-cell tumor'
p282
I1
sS'aml pati'
p283
I1
sS'survival classif'
p284
I1
sS'chemotherapi'
p285
I1
sS'neural net profil'
p286
I1
sS'diagnostic network'
p287
I1
sS'quantitative assess'
p288
I1
sS'fraction'
p289
I1
sS'immunotherapi'
p290
I1
sS'kaplan meier estim'
p291
I1
sS'tool'
p292
I1
sS'software program'
p293
I1
sS'dlbcl lymphoma'
p294
I1
sS'autoimmune diseas'
p295
I1
sS'round-robin fashion'
p296
I1
sS'year prognosi'
p297
I1
sS'tumor reject'
p298
I2
sS'gene expression panel'
p299
I1
sS'numerous recent cancer studi'
p300
I1
sS'diagnosis network'
p301
I1
sS'target'
p302
I2
sS'possibl'
p303
I1
sS'preparation for differenti'
p304
I1
sS'pc'
p305
I1
sS'for limiting tumor growth'
p306
I1
sS'proportional hazard'
p307
I1
sS'recent cancer studi'
p308
I1
sS'network strategi'
p309
I1
sS'tyrosine kinase receptor'
p310
I1
sS'meier estim'
p311
I1
sS'similar'
p312
I4
sS'gene mark'
p313
I1
sS'classif'
p314
I25
sS'fashion'
p315
I1
sS'near-perfect diagnosi'
p316
I1
sS'gene subset'
p317
I4
sS'cutoff criteria'
p318
I1
sS'ann'
p319
I4
sS'diagnosi'
p320
I3
sS'gene predictor'
p321
I1
sS'repres'
p322
I1
sS'round blue-cell tumor'
p323
I1
sS'germinal center b'
p324
I1
sS'b cell-like tumor'
p325
I3
sS'near-perfect classif'
p326
I1
sS'absolute best'
p327
I1
sS'diffuse large b-cell lymphoma'
p328
I1
sS'estim'
p329
I1
sS'normal train'
p330
I1
sS'accuraci'
p331
I12
sS'myeloid leukemia'
p332
I1
sS'efficacious approaches for limiting tumor'
p333
I1
sS'sigmoid transf'
p334
I1
sS'neural network softwar'
p335
I1
sS'kaplan'
p336
I2
sS'donor'
p337
I14
sS'phenotyp'
p338
I1
sS'node'
p339
I1
sS'round-robin'
p340
I1
sS'subsequent network'
p341
I1
sS'ly1'
p342
I1
sS'gene pool'
p343
I1
sS'maximum contribut'
p344
I1
sS'reserve pati'
p345
I1
sS'dlbcl patient'
p346
I3
sS'diagnosis unimpair'
p347
I1
sS'class'
p348
I3
sS'pool'
p349
I2
sS'matrix'
p350
I2
sS'svm'
p351
I1
sS'microarray studi'
p352
I1
sS'for individual pati'
p353
I1
sS'training interv'
p354
I1
sS'individual basi'
p355
I1
sS'rule'
p356
I1
sS'majority pol'
p357
I1
sS'over-train'
p358
I1
sS'profil'
p359
I4
sS'intuit'
p360
I1
stp361
Rp362
tp363
.